Loading...
XNASRKDA
Market cap8mUSD
Dec 27, Last price  
6.11USD
1D
-0.65%
1Q
124.63%
Jan 2017
-99.17%
IPO
-99.90%
Name

Arcadia Biosciences Inc

Chart & Performance

D1W1MN
XNAS:RKDA chart
P/E
—
P/S
1.56
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
67.38%
Rev. gr., 5y
29.49%
Revenues
5m
-46.46%
7,010,0006,478,0006,982,0005,414,0003,188,0004,026,0001,464,0001,169,0008,034,0006,780,0009,956,0005,330,000
Net income
-14m
L-10.45%
-12,370,000-13,195,000-18,339,000-17,956,000-19,624,000-15,707,000-13,480,000-28,873,000-6,026,000-16,134,000-15,612,000-13,981,000
CFO
-15m
L+9.42%
-9,588,000-9,745,000-14,787,000-15,109,000-17,055,000-13,965,000-13,631,000-17,198,000-30,218,000-25,868,000-13,977,000-15,294,000
Earnings
Mar 26, 2025

Profile

Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.
URL
https://arcadiabio.com/
IPO date
May 15, 2015
Employees
30
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
5,330
-46.46%
9,956
46.84%
6,780
-15.61%
Cost of revenue
4,687
11,311
12,597
Unusual Expense (Income)
NOPBT
643
(1,355)
(5,817)
NOPBT Margin
12.06%
Operating Taxes
8
14
2
Tax Rate
1.24%
NOPAT
635
(1,369)
(5,819)
Net income
(13,981)
-10.45%
(15,612)
-3.24%
(16,134)
167.74%
Dividends
Dividend yield
Proceeds from repurchase of equity
5,997
5,000
23,296
BB yield
-154.90%
-76.95%
-105.26%
Debt
Debt current
1,704
1,010
1,074
Long-term debt
1,162
3,024
5,514
Deferred revenue
Other long-term liabilities
3,257
2,806
5,462
Net debt
(8,776)
(16,610)
(22,097)
Cash flow
Cash from operating activities
(15,294)
(13,977)
(25,868)
CAPEX
(5)
(72)
(1,007)
Cash from investing activities
(4,344)
1,417
16,608
Cash from financing activities
5,512
4,519
21,900
FCF
1,463
2,720
(2,990)
Balance
Cash
11,642
20,644
28,685
Long term investments
Excess cash
11,376
20,146
28,346
Stockholders' equity
(271,812)
(257,927)
(226,319)
Invested Capital
290,203
283,650
266,271
ROIC
0.22%
ROCE
3.50%
EV
Common stock shares outstanding
1,237
599
532
Price
3.13
-71.13%
10.84
-73.94%
41.60
-58.89%
Market cap
3,872
-40.41%
6,497
-70.64%
22,132
-12.16%
EV
(5,042)
(10,246)
138
EBITDA
1,627
(876)
(4,772)
EV/EBITDA
11.70
Interest
289
20
Interest/NOPBT